Your browser doesn't support javascript.
loading
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
Sonabend, Raphael; Whittles, Lilith K; Imai, Natsuko; Perez-Guzman, Pablo N; Knock, Edward S; Rawson, Thomas; Gaythorpe, Katy A M; Djaafara, Bimandra A; Hinsley, Wes; FitzJohn, Richard G; Lees, John A; Kanapram, Divya Thekke; Volz, Erik M; Ghani, Azra C; Ferguson, Neil M; Baguelin, Marc; Cori, Anne.
Afiliación
  • Sonabend R; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Whittles LK; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK; National Institute for Health Research Health Protection Research Unit in Modelling Methodology, Imperial College London, Public Health England, London School of Hygiene
  • Imai N; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Perez-Guzman PN; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Knock ES; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK; National Institute for Health Research Health Protection Research Unit in Modelling Methodology, Imperial College London, Public Health England, London School of Hygiene
  • Rawson T; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Gaythorpe KAM; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Djaafara BA; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Hinsley W; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • FitzJohn RG; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Lees JA; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Kanapram DT; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Volz EM; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Ghani AC; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK.
  • Ferguson NM; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK; National Institute for Health Research Health Protection Research Unit in Modelling Methodology, Imperial College London, Public Health England, London School of Hygiene
  • Baguelin M; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK; National Institute for Health Research Health Protection Research Unit in Modelling Methodology, Imperial College London, Public Health England, London School of Hygiene
  • Cori A; MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK; National Institute for Health Research Health Protection Research Unit in Modelling Methodology, Imperial College London, Public Health England, London School of Hygiene
Lancet ; 398(10313): 1825-1835, 2021 11 13.
Article en En | MEDLINE | ID: mdl-34717829
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Control de Enfermedades Transmisibles / Cobertura de Vacunación / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Aspecto: Determinantes_sociais_saude Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Control de Enfermedades Transmisibles / Cobertura de Vacunación / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Aspecto: Determinantes_sociais_saude Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido